Which patients should receive adjuvant treatment - an analysis of stage IIA-IIIA patients of the CMMR
Leiter-Stoppke U, Keim U, Amaral T, Forschner A, Berking C, Gesierich A, Gutzmer R, Sunderkotter C, Utikal JS, Zimmer L, Flatz L, Garbe C (2022)
Publication Type: Conference contribution
Publication year: 2022
Journal
Publisher: WILEY
City/Town: HOBOKEN
Pages Range: 19-19
Conference Proceedings Title: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
Authors with CRIS profile
Involved external institutions
Universitätsklinikum Mannheim
Germany (DE)
Universitätsklinikum Würzburg
Germany (DE)
Universitätsklinikum Essen
Germany (DE)
Universitätsklinikum Halle (Saale)
Germany (DE)
Universitätsklinikum Tübingen
Germany (DE)
Centre Hospitalier Universitaire de Montpellier (CHU/CHRU MTP)
France (FR)
Germany (DE)
Universitätsklinikum Würzburg
Germany (DE)
Universitätsklinikum Essen
Germany (DE)
Universitätsklinikum Halle (Saale)
Germany (DE)
Universitätsklinikum Tübingen
Germany (DE)
Centre Hospitalier Universitaire de Montpellier (CHU/CHRU MTP)
France (FR)
How to cite
APA:
Leiter-Stoppke, U., Keim, U., Amaral, T., Forschner, A., Berking, C., Gesierich, A.,... Garbe, C. (2022). Which patients should receive adjuvant treatment - an analysis of stage IIA-IIIA patients of the CMMR. In JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (pp. 19-19). HOBOKEN: WILEY.
MLA:
Leiter-Stoppke, U., et al. "Which patients should receive adjuvant treatment - an analysis of stage IIA-IIIA patients of the CMMR." Proceedings of the JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT HOBOKEN: WILEY, 2022. 19-19.
BibTeX: Download